Log In
BCIQ
Print this Print this
 

Combivir, lamivudine/zidovudine

Also known as: AZT/3TC

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCombination of two nucleoside analog reverse transcriptase inhibitor
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/20/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today